Inventor
MEIYU GENG
Inventor
CN
Overview
Patents· 18 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes31%
C07DHeterocyclic compounds17%
C07HSugars6%
C08BPolysaccharides6%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for2%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
12,497,394Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereof202512,492,212Substituted pyrazolecarboxamides as sting activators202512,479,850Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereof202512,384,795Pyrimido[5,4-b]pyrrolizin compound, optical isomer thereof, preparation method therefor and use thereof202512,312,324Fluorine-containing substituted benzothiophene compound, and pharmaceutical composition and application thereof202512,269,838Composition of mannuronic diacid202511,834,432Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof202311,661,421Indolizine compounds, preparation method and use thereof202311,655,239Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereof202311,464,794Composition of alginic oligosaccharic diacids202211,465,984Compound having ERK kinase inhibitory activity and use thereof202211,406,652Use of mannuronic diacid composition in treatment of diabetes202211,406,659Use of mannuronic diacid composition in treatment of inflammation202211,406,654Use of mannuronic diacid composition in treatment of Parkinson's disease202211,406,653Use of mannuronic diacid composition in treatment of pain202211,406,651Use of mannuronic diacid composition in treatment of vascular dementia202211,384,111Composition of mannuronic diacid202211,155,569Method of degrading polysaccharide using ozone2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to GREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD (9)· patent assignee history
2021–2025Based in CN· patent location history
2022–2025Patents assigned to SHANGHAI INST MATERIA MEDICA CAS (15)· patent assignee history
2022Patents assigned to GREEN VALLEY SHANGHAI PHARMACEUTICAL CO LTD (1)· patent assignee history
2022Patents assigned to GREEN VALLEY SHANGHAI PHARMACEUTICAL CO LTD SHANGHAI INST OF MATERIA MEDICA CHINESE ACADEMY OF SCIEN (1)· patent assignee history
2023Patents assigned to HAIHE BIOPHARMA CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SHANGHAI INST MATERIA MEDICA CAS | 15 | 2022–2025 |
| GREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD | 9 | 2021–2025 |
| GREEN VALLEY SHANGHAI PHARMACEUTICAL CO LTD | 1 | 2022 |
| GREEN VALLEY SHANGHAI PHARMACEUTICAL CO LTD SHANGHAI INST OF MATERIA MEDICA CHINESE ACADEMY OF SCIEN | 1 | 2022 |
| HAIHE BIOPHARMA CO LTD | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 18 | 2021–2025 |